Literature DB >> 14644345

Transgenerational carcinogenesis: induction and transmission of genetic alterations and mechanisms of carcinogenesis.

Taisei Nomura1.   

Abstract

Parental exposure, i.e. germ cell exposure to radiation and chemicals, increased the incidence of tumors and malformations in the offspring, and the germ-line alterations that cause cancer are transmissible to further generations. However, tumor incidences were 100-fold higher than those of ordinary mouse mutations and there were apparent strain differences in the types of induced tumors. In human, higher risk of leukemia is reported in the children of fathers who had been exposed to radionuclides at the nuclear reprocessing plants or to diagnostic doses of radiation. However, these findings in mice and men have not been confirmed in the children of atomic bomb survivors in Hiroshima and Nagasaki. Another important finding was that germ-line exposure was very weakly tumorigenic by itself. However, the transmissible alterations caused persistent hypersensitivity to tumor induction in the offspring, e.g. enhanced by postnatal treatment with tumor promoting/carcinogenic agents. The above results suggest that transmissible alterations might be imprinted in germ cells for the future development of cancer by the postnatal environment. Many gene loci concerning immunological, biochemical and physiological function might be involved, and the cumulative changes in such genes may slightly elevate or enhance tumor incidences, although mutations of tumor suppressor genes such as p53 were also detected in some offspring and genomic instability may modify tumor occurrence in transgenerational manner. In fact, Gene Chip analysis showed suppression and/or over-expression of many functional genes rather than cancer-related genes in the preconceptionally irradiated cancer prone progeny.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644345     DOI: 10.1016/j.mrrev.2003.06.006

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

Review 1.  What is an epigenetic transgenerational phenotype? F3 or F2.

Authors:  Michael K Skinner
Journal:  Reprod Toxicol       Date:  2007-09-11       Impact factor: 3.143

2.  Introduction: Special Issue on Transplacental/Transgenerational Mutagenesis and Carcinogenesis.

Authors:  Suryanarayana V Vulimiri; Ofelia Olivero
Journal:  Environ Mol Mutagen       Date:  2019-04-25       Impact factor: 3.216

3.  Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain.

Authors:  Anna Kovalchuk; Yaroslav Ilnytskyy; Rafal Woycicki; Rocio Rodriguez-Juarez; Gerlinde A S Metz; Olga Kovalchuk
Journal:  Oncotarget       Date:  2018-01-23

4.  Increased Transgenerational Intestinal Tumorigenesis in Offspring of Ionizing Radiation Exposed Parent APC1638N/+ Mice.

Authors:  Shubhankar Suman; Santosh Kumar; Bo-Hyun Moon; Albert J Fornace; Bhaskar V S Kallakury; Kamal Datta
Journal:  J Cancer       Date:  2017-07-01       Impact factor: 4.207

5.  Epigenetics in radiation biology: a new research frontier.

Authors:  Matt Merrifield; Olga Kovalchuk
Journal:  Front Genet       Date:  2013-04-04       Impact factor: 4.599

6.  Ionizing radiation and childhood leukemia.

Authors:  Abel Russ
Journal:  Environ Health Perspect       Date:  2007-08       Impact factor: 9.031

7.  Transgenerational inheritance of enhanced susceptibility to radiation-induced medulloblastoma in newborn Ptch1⁺/⁻ mice after paternal irradiation.

Authors:  Lorena Paris; Paola Giardullo; Simona Leonardi; Barbara Tanno; Roberta Meschini; Eugenia Cordelli; Barbara Benassi; Maria Grazia Longobardi; Alberto Izzotti; Alessandra Pulliero; Mariateresa Mancuso; Francesca Pacchierotti
Journal:  Oncotarget       Date:  2015-11-03

Review 8.  Ionizing Radiation and Human Health: Reviewing Models of Exposure and Mechanisms of Cellular Damage. An Epigenetic Perspective.

Authors:  Ernesto Burgio; Prisco Piscitelli; Lucia Migliore
Journal:  Int J Environ Res Public Health       Date:  2018-09-10       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.